Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,773 signal articles · 68 in last 24h · 148,348 total before filter · latest 1h ago
68last 24h
974last 7d
109● bullish (7d)
123● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst10
✕ clear all filtersticker: CNCsentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Centene (CNC) Could Be 6% Undervalued Following Renewed Interest In Earnings And ICHRA Growth
Simply Wall St.20h agoneutral
Centene (CNC) Could Be 6% Undervalued Following Renewed Interest In Earnings And ICHRA Growth

Centene (CNC) has moved back into focus after being highlighted for its earnings expectations, an attractive valuation profile, and exposure to growing ICHRA-driven individual coverage through its Ambetter Health Solutions business. Centene’s recent momentum has been hard to ignore, with a 90 day share price return of 9.96% feeding into a 60.60% year to date gain and a 1 year total shareholder return of 108.58%. This suggests investors are reassessing both its earnings profile and perceived...

Is Centene (CNC) Stock Undervalued Right Now?
Zacks1d agoneutral
Is Centene (CNC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet
Trefis3d agoneutral
The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet

UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.

Oscar Health Lowers Medical Cost Outlook. Here's The Caveat.
Investor's Business Daily3d agoneutral
Oscar Health Lowers Medical Cost Outlook. Here's The Caveat.

Oscar Health raised its full-year earnings outlook while lowering its expected medical costs to cover benefits for its nearly 3 million Affordable Care Act exchange members. Oscar, which made an aggressive play to gain ACA market share, has seen enrollment surge 47% from a year ago as of June 30, even as overall enrollment has plunged due to the expiration of enhanced premium subsidies. The ACA's No. 2 insurer by membership behind Centene said that it now expects its medical loss ratio, or benefit costs as a share of premiums, to be in the 81% to 82% range, down from the prior outlook of 81.5% to 82.5%.

3 Value Stocks with Questionable Fundamentals
StockStory10d agoneutral
3 Value Stocks with Questionable Fundamentals

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

UnitedHealth Stock Recovered Before Its Margins Did
Trefis16d agoneutral
UnitedHealth Stock Recovered Before Its Margins Did

UnitedHealth (UNH) stock has gained about 41% since early March, and at roughly $400 a share the market has already paid for a recovery. The easy reading is that the turnaround is finished. It is not. One half got better over those six months, the other got worse, and the price reflects the good half.

Centene (CNC) Names New CIO As Fair Value Debate Stays In Focus
Simply Wall St.16d agoneutral
Centene (CNC) Names New CIO As Fair Value Debate Stays In Focus

Why Centene’s New CIO Matters For Investors Centene (CNC) has put technology in the spotlight with the appointment of Bradley Bolivar as Chief Information Officer, effective 31 August 2026, following Brian LeClaire’s planned retirement. For you as an investor, this move signals a clear intention to rely more on data, artificial intelligence and automation to support operations and financial stability. The market has treated the leadership change as a constructive step that fits with Centene’s...

Is Centene (CNC) a Great Value Stock Right Now?
Zacks17d agoneutral
Is Centene (CNC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Centene (CNC) Hands Its Turnaround Playbook To A New Tech Chief
Insider Monkey17d agoneutral
Centene (CNC) Hands Its Turnaround Playbook To A New Tech Chief

On August 31, Centene Corporation (NYSE:CNC) named Bradley Bolivar its new Chief Information Officer, taking over from Brian LeClaire, who plans to retire by the end of October 2026. Bolivar arrives with nearly three decades of technology leadership, most recently as CIO of Fannie Mae, where his portfolio spanned application development, infrastructure, cybersecurity, data and […]